Enlivex (ENLV) Share-based Compensation (2013 - 2025)
Enlivex's Share-based Compensation was $915,000 in Q4 2025, down 0.2% from $917,000 a year earlier but up 226.8% from the prior quarter.
Powered by 
Analysis
Enlivex (ENLV) Share-based Compensation (2013 - 2025) Analysis & Trends
For FY2025, Share-based Compensation at Enlivex came in at $1.78 million, down 13.7% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 21.6% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $2.07 million in FY2024 (+5.8%), $1.95 million in FY2023 (-28.1%), $2.71 million in FY2022 (-6.9%) and $2.91 million in FY2021 (+334.9%).
- Quarterly Share-based Compensation has moved between $190,000 (Q1 2021) and $1.7 million (Q4 2021) over five years.
- Compared with a year earlier, Share-based Compensation has declined for four straight quarters, with an average decline of 1.9% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q1 2022 (growth of 314.7%); the worst was Q4 2022 (a decline of 55.3%).
- Per Business Quant data, ENLV's Share-based Compensation in the three quarters before Q4 2025 was $280,000 (Q3 2025), $295,000 (Q2 2025) and $293,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Enlivex | 1.58 Mn | -54.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 915,000.00 |
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 295,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | 917,000.00 |
| Sep 30, 2024 | 377,000.00 |
| Jun 30, 2024 | 388,000.00 |
| Mar 31, 2024 | 383,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 407,000.00 |
| Jun 30, 2023 | 511,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 757,000.00 |
| Sep 30, 2022 | 470,000.00 |
| Jun 30, 2022 | 957,000.00 |
| Mar 31, 2022 | 788,000.00 |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 377,000.00 |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 190,000.00 |
API Access
Enlivex Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENLV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ENLV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENLV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();